MiniMed Group Quarterly Cash Flow Statement
NASDAQ: MMEDHealth CareMedical/Dental InstrumentsUSD
19.71-0.09 (-0.45%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
MiniMed Group free cash flow
In the quarter ended Jul 31, 2026, MiniMed Group generated -$49.0 million of operating cash flow and spent $41.0 million on capital expenditures. That left free cash flow of -$90.0 million, a free-cash-flow margin of -10.7% of revenue.
Summary generated from market data by MetaCap's automated system. Methodology
MiniMed Group cash flow statement (quarterly)
| Quarter (USD) | Q1 20272026-07-31 | Q4 20262026-04-24 | Q3 20262026-01-23 | Q2 20262025-10-24 | Q1 20262025-07-25 | Q4 20252025-04-25 | Q3 20252025-01-24 | Q2 20252024-10-25 | Q1 20252024-07-26 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income | 0 | -185.00M | -111.00M | -5.00M | -16.00M | -168.00M | -7.00M | -5.00M | -19.00M |
| Net Income growth (YoY) | — | — | — | — | — | — | — | — | — |
| Depreciation & Amortization | 41.00M | 39.00M | — | — | 39.00M | 38.00M | — | — | — |
| Stock-Based Compensation | 10.00M | 8.00M | 11.00M | — | 9.00M | 9.00M | 11.00M | — | — |
| Change in Working Capital | -15.00M | 64.00M | — | — | -30.00M | 22.00M | — | — | — |
| Operating Cash Flow | -49.00M | -170.00M | — | — | -141.00M | 83.00M | — | — | — |
| Capital Expenditures | -41.00M | -56.00M | — | — | -53.00M | -57.00M | — | — | — |
| Investing Cash Flow | -41.00M | -56.00M | — | — | -63.00M | -57.00M | — | — | — |
| Financing Cash Flow | 0 | 512.00M | — | — | 202.00M | -25.00M | — | — | — |
| Net Change in Cash | -91.00M | 287.00M | — | — | -2.00M | 1.00M | — | — | — |
| Free Cash Flow | -90.00M | -226.00M | — | — | -194.00M | 26.00M | — | — | — |
This table shows 9 quarterly periods of MiniMed Group's cash flow statement, from Q1 2027 back to Q1 2025, across 10 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow MMED's reporting calendar. What is a cash flow statement?